Ignite Creation Date:
2025-12-24 @ 1:36 PM
Ignite Modification Date:
2026-01-09 @ 5:32 AM
Study NCT ID:
NCT06496295
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-09-25
First Post:
2024-07-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Use of a Novel Vaginal Speculum for Cervical Cancer Screening in Sunrise Community Health Patients
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 200}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'ENROLLING_BY_INVITATION', 'startDateStruct': {'date': '2024-11-14', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-09', 'completionDateStruct': {'date': '2025-12-30', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2025-09-24', 'studyFirstSubmitDate': '2024-07-03', 'studyFirstSubmitQcDate': '2024-07-10', 'lastUpdatePostDateStruct': {'date': '2025-09-25', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2024-07-11', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2025-12-30', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Evaluating the use of the Bouquet Speculum for cervical visibility, ease-of-use, and comfort level', 'timeFrame': '3 months', 'description': '200 women will be selected from the Sunrise Clinics in the Denver-Metro area. The clinician will then be assigned a letter and complete three questions on a survey for each patient regarding 1. visualization of the cervix 2. ease-of-use 3. experience with speculum exams. The patient will be consented and de-identified and assigned a number to their survey of four questions: 1. comfort level 2. last vaginal speculum exam 3. self-reported description of weight (underweight, normal, overweight, obese) 4. parity (number of births).\n\nThe Bouquet Speculum has been FDA-cleared and is a Class II medical device and poses a non-significant risk for use in humans. Regulation Number: 884.4520'}]}, 'oversightModule': {'isUsExport': True, 'oversightHasDmc': True, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': True}, 'conditionsModule': {'keywords': ['Vaginal Speculum', 'Cervical Cancer Screening'], 'conditions': ['Cervical Cancer Screening']}, 'referencesModule': {'references': [{'pmid': '37790696', 'type': 'BACKGROUND', 'citation': 'Bouquet JM, Naji R, Armas CA, Roldan V, Selkhi S, Bentley CZ, Zapata I, Fisher J. An Innovative Design for the Vaginal Speculum. Med Devices (Auckl). 2023 Sep 25;16:211-218. doi: 10.2147/MDER.S415558. eCollection 2023.'}], 'seeAlsoLinks': [{'url': 'https://www.longdom.org/open-access/a-new-vaginal-speculum-and-an-inexpensive-kit-to-screen-and-treat-dysplasia-and-cancer-of-the-cervix-44231.html', 'label': "Publication in the Journal of Women's Health"}]}, 'descriptionModule': {'briefSummary': "The specific aim of this research is to determine if the Bouquet Speculum TM , compared to the existing 2-bladed vaginal speculum, provides better visualization of the cervix, is easier for the provider to use and is more comfortable for the patient.\n\nAdditionally, the clinician's experience with vaginal speculum exams and the patient's last vaginal speculum exam, parity and self-reported weight classification will be surveyed to see what effect, if any, it has on visualization of the cervix, ease-of use, and comfort level for the patient.\n\nThe objective of this project is to investigate the use of a novel, FDA-cleared, 5-petaled vaginal speculum in cervical cancer screening (Pap test and/or HPV probe) on 200 patients from Sunrise Community Health Clinics in the Denver-Metro area.", 'detailedDescription': 'The Bouquet Speculum TM will be used by a variety of clinicians at Sunrise Clinics including physicians, PAs, and NPs for routine cervical cancer screening including Pap tests and/or HPV probes. 200 women will be selected from the Sunrise Clinics in the Denver-Metro area. Women who do not have a cervix or have never had a vaginal speculum exam will be excluded. The inclusion criteria is women ages 18-65.\n\nThe clinician will be provided with a one-page Instructions for Use document and a 2-minute instructional video on how to use the Bouquet Speculum TM. The clinician will then be assigned a letter and complete three questions on a survey for each patient regarding 1. visualization of the cervix 2. ease-of-use 3. experience with speculum exams. The patient will be consented and de-identified and assigned a number to their survey of four questions: 1. comfort level 2. last vaginal speculum exam 3. self-reported description of weight (underweight, normal, overweight, obese) 4. parity (number of births).\n\nThe length of the study is anticipated to be three months. The surveys will be collected and tabulated and then evaluated by Dr. Mark Payton who has experience with the Pakistan study.\n\nThe Bouquet Speculum has been FDA-cleared and is a Class II medical device and poses a non-significant risk for use in humans.\n\nProprietary Name: Bouquet Vaginal Speculum Classification Name: RETRACTOR, VAGINAL Product Code: HDL Device Class:2 Regulation Number: 884.4520 Medical Specialty: Obstetrics/Gynecology Registered Establishment Name: Viospex Registered Establishment Number:3012447313 Owner/Operator: Viospex Owner/Operator Number:10051911 Establishment Operations: Manufacture'}, 'eligibilityModule': {'sex': 'FEMALE', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '65 Years', 'minimumAge': '18 Years', 'genderBased': True, 'samplingMethod': 'PROBABILITY_SAMPLE', 'studyPopulation': 'Sunrise Community Health Clinics provide affordable health care to the uninsured and underinsured. This particular study involves women or gender diverse patients with a cervix and who have had a previous vaginal speculum exam.', 'genderDescription': 'Women, gender diverse patients with an intact cervix', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* women, gender diverse patients with an intact cervix\n* women ages 18-25\n\nExclusion Criteria: no prior vaginal speculum exam\n\n* under age 18 or over age 65\n* lack of a uterine cervix\n* no prior vaginal speculum exam'}, 'identificationModule': {'nctId': 'NCT06496295', 'briefTitle': 'The Use of a Novel Vaginal Speculum for Cervical Cancer Screening in Sunrise Community Health Patients', 'organization': {'class': 'OTHER', 'fullName': 'Rocky Vista University, LLC'}, 'officialTitle': 'Evaluating the Efficacy and Use of the Bouquet Speculum for Cervical Cancer Screening in a Diverse Population of Patients', 'orgStudyIdInfo': {'id': 'IRB #2023-266'}}, 'armsInterventionsModule': {'interventions': [{'name': 'Vaginal Speculum Exam', 'type': 'DEVICE', 'description': 'Evaluating the visibility of the cervix, ease-of-use, and comfort of a new vaginal speculum.'}]}, 'contactsLocationsModule': {'locations': [{'zip': '80112', 'city': 'Englewood', 'state': 'Colorado', 'country': 'United States', 'facility': 'Rocky Vista University', 'geoPoint': {'lat': 39.64777, 'lon': -104.98776}}], 'overallOfficials': [{'name': 'Jean Bouquet, DO', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Rocky Vista University'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Rocky Vista University, LLC', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}